Consumption of Garlic and Risk of Colorectal Cancer: an Updated Meta-Analysis of Prospective Studies.

Ji-Yi Hu,Yi-Wang Hu,Jiao-Jiao Zhou,Meng-Wen Zhang,Dan Li,Shu Zheng
DOI: https://doi.org/10.3748/wjg.v20.i41.15413
2014-01-01
Abstract:AIM:To conduct an updated meta-analysis of prospective studies addressing the association between garlic consumption and colorectal cancer.METHODS:Eligible cohort studies were identified by searching MEDLINE (PubMed) and screening the references of related articles published up to October 2013. Meta-analyses were conducted for colorectal cancer in relation to consumption of raw and cooked (RC) garlic and garlic supplements, separately. The summary relative risks (RR) with 95%CI were calculated using fixed-effects or random-effects model depending on the heterogeneity among studies.RESULTS:A total of 5 prospective cohort studies were identified. In contrast to the previous meta-analysis, no significant associations were found between consumption of RC garlic (RR: 1.06; 95%CI: 0.95-1.19) or garlic supplements (RR: 1.12; 95%CI: 0.96-1.31) and risk of colorectal cancer. A non-significant protective effect of garlic supplement intake against colorectal cancer was observed in females (RR: 0.84; 95%CI: 0.64-1.11), but the opposite was the case in males (RR: 1.24; 95%CI: 0.96-1.59).CONCLUSION:Consumption of RC garlic or garlic supplements is not significantly associated with reduced colorectal cancer risk.
What problem does this paper attempt to address?